期刊文献+

TD对Graves’病^(131)I疗效影响的对比研究 被引量:6

The Effects of ATD for the Treatment of ^(131)I in Graves' Disease
下载PDF
导出
摘要 目的 探讨ATD(抗甲状腺药物 )对Graves’病13 1I治疗疗效的影响程度 ,指导临床更加合理地使用13 1I治疗剂量 .方法 选取 80例已服用ATD的Graves’病患者按停服ATD时间长短分成 4组 .全部行吸碘率检查及13 1I治疗 ;再按服用ATD时间长短分为 3组 ,以 2 0例未服ATD即行13 1I治疗者为对照组 ,比较 2 4小时最高吸碘率及13 1I治疗疗效.结果 未服用ATD者 2 4小时最高吸碘率和13 1I治愈率最高 ,停用ATD时间越短 ,最高吸碘率和治愈率越低 ;服用ATD时间越长 ,13 1I治疗的疗效越差 .结论 ATD能较明显影响Graves’病13 1I的疗效 ,是13 Objective To investigate the influence of ATD on 131 I treatment in Graves' disease and to evaluate reasonable dosage of 131 I for the treatment of Graves' disease. Methods 80 cases of Graves' disease had been treated with ATD and they were divided into four groups. the first group stoped taking ATD 7 days before 131 I treatment;the second group stoped at 15 days before 131 I treatment;the third group stoped taking ATD beyond 15 days before 131 I treatment;the fourth group continued to take ATD.All the patients received examination for thyroid putake Ratio (TUR) absorption and 131 I treatment. The following treatment were divided into 3 groups:the first group had taken ATD less than 1 year,the second group had taken ATD for 1~5 years;the third group had taken ATD over 5 years;and 20 cases had not taken ATD when they visited doctor but treated by 131 I were set as control. Iodine absorption peak and 131 I treatment effects were evaluated. Results Patients had not taken ATD b ut treated by 131 I had the highest iodine absorption peak and cured rate,the shorter time of stop taking ATD,the lower of iodine absorption peak and cure rate;the longer time of taking ATD,the worse effects of 131 I treatment. Conclusion ATD could apperently effect the therapeutical effec ts of 131 I treatment of Graves' disease,and It is a factor must be comprehensively considered when 131 I treatment is applied.
出处 《现代临床医学生物工程学杂志》 2004年第1期37-38,共2页 Journal of Modern Clinical Medical Bioengineering
关键词 ATD Graves’病 ^131I治疗 抗甲状腺药物 临床资料 自身免疫性疾病 ATD Graves' disease 131 I treatment
  • 相关文献

参考文献2

二级参考文献10

  • 1Freitas JE,Swanson DP,Gross MD,et al.Iodine131: optimal therapy for hyperthyroidism in children and adolescents?[].The Journal of Nuclear Medicine.1979
  • 2Viti P,Rago T,Chiovato L,et al.Clinical feature at diagnosis and responses to medical therapy[].Thyroid.1997
  • 3Hamburger JI.Management of hyperthyroidism in children and adolescents[].The Journal of Clinical Endocrinology.1985
  • 4Rudberg C,Johansson H,Akerstrom G,et al.Graves’ disease in children and adolescents, late results of surgical treatment[].European Journal of Endocrinology.1996
  • 5Hall P,Mattsson A,Boice Jr JD.Thyroid cancer after diagnostic administration of iodine-131[].Radiation Research.1996
  • 6Links JM,Wanger HN.The thyroid: a fundamental and clinical text[]..1995
  • 7Rivkees SA,Sklar C,Freemark M.The management of Graves’ disease in children, with special emphasis on radioiodine treatment[].Journal of Clinical Endocrinology and Metabolism.1998
  • 8Sheline GE,Lindsay S,Mccormack KR,et al.Thyroid nodules occurring late affer treatment of thyrotoxicosis with radioiodine[].The Journal of Clinical Endocrinology.1962
  • 9Kogut MD,Kaplan SA,Collipp PJ,et al.Treatment of hyperthyroidisim in children, analysis of forty-five patients[].The New England Journal of Medicine.1965
  • 10Robertson JS,Gorman CA.Gonadal radiation dose and its genetic significant in radioiodine therapy at hyperthyroidism[].The Journal of Nuclear Medicine.1976

共引文献61

同被引文献41

  • 1施洪波,徐文媛,王永丽.抗甲状腺药物ATD在用^(131)I治疗甲状腺机能亢进症中对疗效影响的研究[J].中国地方病防治,2004,19(6):340-341. 被引量:1
  • 2潘明志.抗甲状腺药物对甲状腺摄^(131)I率影响的比较研究[J].四川大学学报(医学版),2005,36(3):443-444. 被引量:5
  • 3石根明,徐勤,杨以理,叶安方,朱诚忆.甲亢手术与丙基硫氧嘧啶对^(131)I疗效的影响[J].中华放射医学与防护杂志,2006,26(1):68-70. 被引量:3
  • 4Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodine treatment : systematic review and meta-analysis of randomised controlled trials. BMJ, 2007,334 ( 10 ) : 514-520.
  • 5Imseis RE, Venmiddlesworth L, Massie JD, et al, Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab, 1998, 83 (2) : 685-687.
  • 6Santos RB, Romaldini JH, Ward LS. Propylthiouraeil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. Thyroid, 2004,14 ( 7 ) : 525-530.
  • 7Bonnema SJ, Bennedbaek FN, Veje A, et al. Prepylthiouraeil before ^131I therapy of hyperthyroid diseases:effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab, 2004, 89 (9): 4439-4444.
  • 8Allahabadia A, Daykin J, Holder RL, et al. Age and gender predict the outcome of treatment for Graves' hyperthyroidism, J Clin Endocrinol Metab, 2000,85(3) : 1038-1042.
  • 9Cooper DS, Drug therapy:antithyroid drugs. N Engl J Med,2005,352 (9) :905-917.
  • 10Bonnema S J, Bennedbaek FN,Veje A,et al. Propylthiouracil before ^131I therapy of hyperthyroid diseases:effect on cure rate evaluated by a randomized clinical trial [J]. J Clin Endocrinol Metab,2004,89 ( 9 ) : 4439-4444.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部